Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

Overview

Journal Ann Surg

Specialty General Surgery

Date 2005 Dec 24

PMID 16371744

Citations 382

Authors

Carel W le Roux

Simon J B Aylwin

Rachel L Batterham

Cynthia M Borg

Frances Coyle

Vyas Prasad

Sandra Shurey

Mohammad A Ghatei

Ameet G Patel

Stephen R Bloom

Affiliations

Soon will be listed here.

Abstract

Objective: To study the effect of bariatric surgery on the entero-hypothalamic endocrine axis of humans and rodents.

Background: Bariatric surgery is the most effective obesity treatment as it achieves substantial and sustained weight loss. Glycemic control and enhanced satiation improve before substantial weight loss occurs. Gut peptides, acting both peripherally and centrally, contribute to glycemic control and regulate food intake.

Methods: We examined meal-stimulated responses of insulin, ghrelin, peptide YY (PYY), glucagon-like-peptide-1 (GLP-1), and pancreatic polypeptide (PP) in humans and rodents following different bariatric surgical techniques.

Results: Compared with lean and obese controls, patients following Roux-en-Y gastric bypass (RYGB) had increased postprandial plasma PYY and GLP-1 favoring enhanced satiety. Furthermore, RYGB patients had early and exaggerated insulin responses, potentially mediating improved glycemic control. None of these effects were observed in patients losing equivalent weight through gastric banding. Leptin, ghrelin, and PP were similar in both the surgical groups. Using a rodent model of jejuno-intestinal bypass (JIB), we showed elevated PYY and GLP-1 in JIB rats compared with sham-operated rats. Moreover, exogenous PYY reduced food intake and blockade of endogenous PYY increased food intake. Thus, higher plasma PYY following JIB may contribute to reduced food intake and contribute to weight loss.

Conclusions: Following RYGB and JIB, a pleiotropic endocrine response may contribute to the improved glycemic control, appetite reduction, and long-term changes in body weight.

Citing Articles

Bile acids and metabolic surgery.

Xue H, Huang L, Tu J, Ding L, Huang W Liver Res. 2025; 5(3):164-170.

PMID: 39957846 PMC: 11791848. DOI: 10.1016/j.livres.2021.05.001.

Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders.

Cortes-Martin A, Plaza-Diaz J World J Gastroenterol. 2025; 31(4):101436.

PMID: 39877709 PMC: 11718636. DOI: 10.3748/wjg.v31.i4.101436.

Incretin-based therapy: a new horizon in diabetes management.

Zarei M, Sahebi Vaighan N, Farjoo M, Talebi S, Zarei M J Diabetes Metab Disord. 2024; 23(2):1665-1686.

PMID: 39610543 PMC: 11599551. DOI: 10.1007/s40200-024-01479-3.

Plasma concentration of gastrointestinal hormones and subjective appetite ratings after diet or bariatric surgery: 1-year results from the DISGAP study.

Aukan M, Rehfeld J, Holst J, Martins C Int J Obes (Lond). 2024; 49(2):306-314.

PMID: 39572763 DOI: 10.1038/s41366-024-01658-5.

Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy.

Chen S, Zeng Q, Cai X, Xue J, Yin G, Song P Int J Biol Sci. 2024; 20(11):4438-4457.

PMID: 39247824 PMC: 11380448. DOI: 10.7150/ijbs.98362.

References

Batterham R, Cowley M, Small C, Herzog H, Cohen M, Dakin C . Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002; 418(6898):650-4. DOI: 10.1038/nature00887. View

Kenler H, Brolin R, Cody R . Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr. 1990; 52(1):87-92. DOI: 10.1093/ajcn/52.1.87. View

Craig B, Tseng D . Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002; 113(6):491-8. DOI: 10.1016/s0002-9343(02)01266-4. View

Faraj M, Havel P, Phelis S, Blank D, Sniderman A, Cianflone K . Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003; 88(4):1594-602. DOI: 10.1210/jc.2002-021309. View

Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M . Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 2003; 124(5):1325-36. DOI: 10.1016/s0016-5085(03)00216-6. View

Schwartz M, Woods S, Porte Jr D, Seeley R, Baskin D . Central nervous system control of food intake. Nature. 2000; 404(6778):661-71. DOI: 10.1038/35007534. View

Bray G, Tartaglia L . Medicinal strategies in the treatment of obesity. Nature. 2000; 404(6778):672-7. DOI: 10.1038/35007544. View

Tschop M, Smiley D, Heiman M . Ghrelin induces adiposity in rodents. Nature. 2000; 407(6806):908-13. DOI: 10.1038/35038090. View

Pories W, MacDonald Jr K, MORGAN E, Sinha M, Dohm G, Swanson M . Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992; 55(2 Suppl):582S-585S. DOI: 10.1093/ajcn/55.2.582s. View

10.

Pories W, Swanson M, MacDonald K, Long S, Morris P, Brown B . Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222(3):339-50; discussion 350-2. PMC: 1234815. DOI: 10.1097/00000658-199509000-00011. View

11.

Naslund E, Gryback P, Hellstrom P, Jacobsson H, Holst J, Theodorsson E . Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord. 1997; 21(5):387-92. DOI: 10.1038/sj.ijo.0800418. View

12.

Naslund E, Melin I, Gryback P, Hagg A, Hellstrom P, Jacobsson H . Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr. 1997; 66(1):26-32. DOI: 10.1093/ajcn/66.1.26. View

13.

Kortt M, Langley P, Cox E . A review of cost-of-illness studies on obesity. Clin Ther. 1998; 20(4):772-9. DOI: 10.1016/s0149-2918(98)80140-9. View

14.

Gutzwiller J, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D . Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1998; 44(1):81-6. PMC: 1760073. DOI: 10.1136/gut.44.1.81. View

15.

Mason E . Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999; 9(3):223-8. DOI: 10.1381/096089299765553070. View

16.

Saper C, Chou T, Elmquist J . The need to feed: homeostatic and hedonic control of eating. Neuron. 2002; 36(2):199-211. DOI: 10.1016/s0896-6273(02)00969-8. View

17.

Mitchell J, Lancaster K, Burgard M, HOWELL L, Krahn D, Crosby R . Long-term follow-up of patients' status after gastric bypass. Obes Surg. 2001; 11(4):464-8. DOI: 10.1381/096089201321209341. View

18.

Wren A, Seal L, Cohen M, Brynes A, Frost G, Murphy K . Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001; 86(12):5992. DOI: 10.1210/jcem.86.12.8111. View

19.

Imamura M . Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides. 2002; 23(2):403-7. DOI: 10.1016/s0196-9781(01)00618-0. View

20.

Cummings D, Weigle D, Frayo R, Breen P, Ma M, Dellinger E . Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002; 346(21):1623-30. DOI: 10.1056/NEJMoa012908. View